180 related articles for article (PubMed ID: 14594332)
21. [Clinical report on pharmacological treatment of autism].
Thivierge J
Sante Ment Que; 1998; 23(1):85-95. PubMed ID: 9775955
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder.
Wink LK; Pedapati EV; Adams R; Erickson CA; Pedersen KA; Morrow EM; Kaplan D; Siegel M;
J Autism Dev Disord; 2018 Nov; 48(11):3711-3719. PubMed ID: 28516426
[TBL] [Abstract][Full Text] [Related]
23. Increase in Psychoactive Drug Prescriptions in the Years Following Autism Spectrum Diagnosis: A Population-Based Cohort Study.
Croteau C; Mottron L; Presse N; Tarride JE; Dorais M; Perreault S
J Popul Ther Clin Pharmacol; 2017 Aug; 24(3):e19-e32. PubMed ID: 28873291
[TBL] [Abstract][Full Text] [Related]
24. Psychopharmacoepidemiology of mental retardation: 1966 to 1995.
Singh NN; Ellis CR; Wechsler H
J Child Adolesc Psychopharmacol; 1997; 7(4):255-66. PubMed ID: 9542696
[TBL] [Abstract][Full Text] [Related]
25. Profile of psychotropic agents used in autism spectrum disorder according to comorbidities in Turkey: A 4-year evaluation.
Karabacak Y; Barun S; Vural İM; Vural E; Iseri E; Kahve AC; Yilmaz EŞ; Isli F; Turkes S; Ezber E; Paykal G
Int Clin Psychopharmacol; 2023 Jul; 38(4):216-222. PubMed ID: 36752705
[TBL] [Abstract][Full Text] [Related]
26. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
Curran S; Turner D; Musa S; Wattis J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
[TBL] [Abstract][Full Text] [Related]
27. Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.
Aman MG; Sarphare G; Burrow WH
Am J Ment Retard; 1995 Mar; 99(5):500-9. PubMed ID: 7779345
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Psychoactive Drugs on Seizures and Antiepileptic Drugs.
Habibi M; Hart F; Bainbridge J
Curr Neurol Neurosci Rep; 2016 Aug; 16(8):71. PubMed ID: 27315249
[TBL] [Abstract][Full Text] [Related]
29. Psychopharmacology in autism.
Tsai LY
Psychosom Med; 1999; 61(5):651-65. PubMed ID: 10511014
[TBL] [Abstract][Full Text] [Related]
30. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
Winterstein AG; Soria-Saucedo R; Gerhard T; Correll CU; Olfson M
J Clin Psychiatry; 2017 Jul; 78(7):e744-e781. PubMed ID: 28686819
[TBL] [Abstract][Full Text] [Related]
31. Pharmacotherapy of target symptoms in autistic spectrum disorders.
Santosh PJ; Baird G
Indian J Pediatr; 2001 May; 68(5):427-31. PubMed ID: 11407159
[TBL] [Abstract][Full Text] [Related]
32. Psychotropic medication in children and adolescents in the United States in the year 2004 vs 2014.
Lopez-Leon S; Lopez-Gomez MI; Warner B; Ruiter-Lopez L
Daru; 2018 Sep; 26(1):5-10. PubMed ID: 30159759
[TBL] [Abstract][Full Text] [Related]
33. Use of psychotropic medication in children and adolescents with autism spectrum disorders.
Coury DL; Anagnostou E; Manning-Courtney P; Reynolds A; Cole L; McCoy R; Whitaker A; Perrin JM
Pediatrics; 2012 Nov; 130 Suppl 2():S69-76. PubMed ID: 23118256
[TBL] [Abstract][Full Text] [Related]
34. Antiepileptic drugs: affective use in autism spectrum disorders.
Di Martino A; Tuchman RF
Pediatr Neurol; 2001 Sep; 25(3):199-207. PubMed ID: 11587873
[TBL] [Abstract][Full Text] [Related]
35. Psychotropic effects of antiepileptic drugs.
Ettinger AB
Neurology; 2006 Dec; 67(11):1916-25. PubMed ID: 17159095
[TBL] [Abstract][Full Text] [Related]
36. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
[TBL] [Abstract][Full Text] [Related]
37. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
[TBL] [Abstract][Full Text] [Related]
38. Psychotropic Medication Use During Inpatient Rehabilitation for Traumatic Brain Injury.
Hammond FM; Barrett RS; Shea T; Seel RT; McAlister TW; Kaelin D; Ryser DK; Corrigan JD; Cullen N; Horn SD
Arch Phys Med Rehabil; 2015 Aug; 96(8 Suppl):S256-3.e14. PubMed ID: 26212402
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy of irritability in pervasive developmental disorders.
Stigler KA; McDougle CJ
Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
[TBL] [Abstract][Full Text] [Related]
40. National patterns in the outpatient pharmacological management of children and adolescents with autism spectrum disorder.
Gerhard T; Chavez B; Olfson M; Crystal S
J Clin Psychopharmacol; 2009 Jun; 29(3):307-10. PubMed ID: 19440093
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
